Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. [Phase 1, Phase 2]
Clinical trial update reports safety assessment of T4090 eye drops in patients with ocular hypertension or glaucoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial update for a therapeutic equivalence study in primary open-angle glaucoma or ocular hypertension; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2a randomized trial evaluating the efficacy and safety of TFC-003 in primary open-angle glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. [Phase 4]
Phase 4 trial comparing two PF-formulation eye drops for open-angle glaucoma and ocular hypertension; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial update for Travoprost ophthalmic topical cream addressing open-angle glaucoma and ocular hypertension is in progres…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 confirmatory trial evaluating STN1012600 in adults with primary open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 trial comparing T4032 to Lumigan in ocular hypertension or glaucoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells [Phase 4]
Phase 4 trial evaluating the effect of benzalkonium chloride-preserved vs preservative-free latanoprost eye drops on conjunctival goblet cel…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Clinical trial update for TO-O-1001 eye drops evaluating IOP-lowering effects in healthy subjects and patients with open-angle glaucoma or o…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Clinical Study Comparing Two Models of a Travoprost Intraocular Implant [Phase 3]
Phase 3 clinical study comparing two models of a travoprost intraocular implant in glaucoma and ocular hypertension completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% [Phase 3]
Phase 3 randomized study comparing two travoprost intraocular implant models to timolol maleate ophthalmic solution 0.5%; results have been …
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study [Phase 3]
A Phase III study comparing DE-117 ophthalmic solution to timolol for glaucoma or ocular hypertension completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: DE-117 Spectrum 5 Study [Phase 3]
Phase 3 trial update for DE-117 Spectrum 5 in primary open-angle glaucoma and ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months [Phase 2]
A Phase 2 trial evaluating the safety and ocular hypotensive effect of AR-12286 in patients with elevated intraocular pressure, completed.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study [Phase 3]
Phase III study comparing DE-117 ophthalmic solution to timolol for glaucoma or ocular hypertension; trial completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients. [Phase 3]
A Phase 3 trial comparing T4030 Eye Drops with Ganfort in patients with ocular hypertension or glaucoma has completed, assessing efficacy an…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma [Phase 2]
Phase 2 trial update on safety and efficacy of ophthalmic phentolamine mesylate for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert [Phase 3]
Phase 3 study completed evaluating the long-term safety of the sustained-release travoprost intracanalicular insert (OTX-TP).
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3b study evaluating 24-hour intraocular pressure lowering effect of Bimatoprost SR in open-angle glaucoma or ocular hypertension has c…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma [Phase 2]
A Phase 2 trial investigating AKB-9778 ophthalmic solution as an adjunct to latanoprost in ocular hypertension or primary open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update for Levobetaxolol Hydrochloride Eye Drops in primary open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Safety and IOP-Lowering Effects of WB007 [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and intraocular pressure-lowering effects of WB007 in glaucoma and ocular hypertension. Results have been …
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's product to FDA-approved treatment for glaucoma or ocular hypertension has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial comparing netarsudil 0.02% with ripasudil 0.4% in Japanese patients with primary open angle glaucoma or ocular hypert…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 multicenter trial comparing DE-126 ophthalmic solution to timolol in primary open-angle glaucoma or ocular hypertension has comple…